Bipolar Disorder Increases Odds of Mortality More Than Smoking
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 9, 2024 -- Bipolar disorder (BD) increases the odds of mortality more than a history of smoking, according to a study published in the December issue of Psychiatry Research.
Anastasia K. Yocum, Ph.D., from the University of Michigan in Ann Arbor, and colleagues analyzed observational data from the Prechter Longitudinal Study of Bipolar Disorder (PLS-BD) for 1,128 participants (including 281 controls) to quantify mortality rates compared to common comorbidities and causes of death. A replication, observational secondary data analysis was conducted using a cohort of 10,735 existing BD patients and 7,826 controls from the University of Michigan Health (U-M Health) clinic.
The researchers found that in both PLS-BD and U-M Health, the mortality rates differed significantly for those with BD and controls. A higher percentage of elevated depression measures was seen for those with BD who were deceased, but no difference was seen in mania or anxiety measures, or in patterns of medication use. A BD diagnosis increased the odds of mortality more than a history of smoking or age 60 years or older in both cohorts.
"Bipolar disorder is never going to be listed on the death certificate as the main cause of death, but it can be an immediate or secondary contributor to a death, including in suicides," Yocum said in a statement.
One author disclosed ties to Janssen and Otsuka Pharmaceuticals.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-10 22:15
Read more
- FDA Proposes Nicotine Limits on Combustible Tobacco Products
- Risk for Head and Neck Cancer Lower for Coffee and Tea Drinkers
- Position Statement Developed for Managing Blood Cancers in Pregnancy
- Gestational Exposure to NSAIDs Tied to Childhood Chronic Kidney Disease
- Use Your Freezer to Fight Food Waste, Protect the Planet
- First-Time Moms In This State May Be Using Welfare for Paid Family Leave
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions